氧气增强的双截面微针贴片用于增强药物透和改善牛皮的光动力学和抗炎疗法
Yaqi Yuan1, Peng Jiang1, Chuan Xiao2
1Department of Stomatology, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.
Acta pharmaceutica Sinica. B
|January 26, 2026
概括
一种新型的微针贴片提供三氨酸 (TA) 纳米颗粒和氧气,有效治疗牛皮. 这种S-PTP MN贴片提高了药物透率和光动力疗法的疗效,以更好地管理皮肤状况.
科学领域:
- 皮肤病学 皮肤病学
- 纳米技术纳米技术
- 生物材料是一种生物材料.
背景情况:
- 牛皮是一种慢性炎症性皮肤疾病,表皮变厚,阻碍局部治疗.
- 牛皮的炎症微环境限制了药物透和光动力疗法 (PDT) 的有效性.
研究的目的:
- 开发和评估用于增强牛皮治疗的双截面微针 (MN) 补丁 (S-PTP MN补丁).
- 通过微针技术提高药物输送和PDT的疗效.
主要方法:
- 在S-PTP MN补丁具有TPP纳米颗粒 (NP) 与三氨酸 (TA) 和反应性氧物种 (ROS) 响应层.
- 补丁基含有碳酸 (SPC) 用于氧气生成,增强NP透和PDT.
- 通过 PTP NPs,通过 PTP NPs,在6天内持续释放TA.
主要成果:
- 与局部TA奶油相比,S-PTP MN补丁在因米奎莫德诱导的牛皮小鼠模型中显示出更高的治疗效果.
- 观察到临床症状显著缓解,表皮厚度降低,炎症性细胞因子水平降低.
- 该贴片促进了PTPNP的深入透到炎症部位.
结论:
- S-PTP MN贴片通过增强药物输送和PDT提供了一种有希望的策略,用于有效治疗牛皮.
- 双截面微针设计改善了慢性炎症性皮肤疾病的治疗结果.
- 这种方法有可能用于治疗牛皮的临床转化.
相关概念视频
Drug Therapy
265
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
265
Bioavailability Enhancement: Drug Solubility Enhancement
255
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
255
Bioavailability Enhancement: Drug Permeability Enhancement
197
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
197
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
206
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
206
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.8K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.8K
Drug Administration and Therapy Phases: Overview
1.4K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.4K


